Driving innovation through competition.

About Generics

The Science of Generic Medicines

Affordability & Sustainable Health

Intellectual Property

Further Resources

Generic Medicines and Affordability

Generics, Affordability & Sustainable Healthcare

As Europe’s population grows older and demands for healthcare provision increase, Europe is facing a nightmare scenario of rapidly increasing healthcare costs. Increasing the use of affordable generic medicines offers a partial solution to the problem ...

Increasing patient access to generic medicines generates four principle public health benefits: 1) Reduced Prices; 2) Stimulation of Competition; 3) Creation of Budget Headroom for Innovation; 4) Encouraging the creation of new pharmaceutical companies...

It is in the area of critical illness, where pharmaceuticals are mostly paid for indirectly through health insurance and tax contributions, that generic medicines play the most crucial role in Europe...

The budgetary importance of generic medicines is not the only aspect that is driving policy-makers to consider them more seriously. Generic medicines are now recognised as a major instrument for promoting pharmaceutical competition, innovation and employment in the EU...

It is by now generally recognised that the lack of pharmaceutical innovation in Europe is not due to deficient market protection for pharmaceuticals. Europe’s failure to keep pace with the United States’ record on innovation is rooted in other problems...